title: Improving outcomes for retroperitoneal sarcomas: a work in progress.
abstract: This article presents the current understanding of prognostic factors and outcomes for retroperitoneal sarcoma. The discussion focuses on the literature published since 2000, including studies with cohorts of at least 30 patients. An interpretation of factors that have contributed to an improvement in outcomes has been performed. With demonstration of the potential for good long-term outcomes and a better appreciation for the importance of minimizing treatment-related morbidity, the international sarcoma community has increasingly recognized and emphasized the importance of expert multidisciplinary assessment and care for this rare malignancy.
authors.affiliation: Department of Surgery, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada. cswallow@mtsinai.on.ca
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Swallow
authors.forename: Charles N
authors.initials: CN
authors.lastname: Catton
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D060787:Neoplasm Grading; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery; D010348:Patient Care Team; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012186:Retroperitoneal Neoplasms / Q000401:mortality / Q000601:surgery*; D012509:Sarcoma / Q000601:surgery*; D012983:Soft Tissue Neoplasms / Q000401:mortality / Q000601:surgery*; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed